Literature DB >> 8946626

Molecular prognostic factor in renal cell carcinoma.

T Shimazui1, E Oosterwijk, F M Debruyne, J A Schalken.   

Abstract

Renal cell carcinoma (RCC) is characterized by an unpredictable clinical course. Therefore, prognostic factors are urgently needed. So far, clinical staging is the most powerful predictor of the progression of RCC. A better understanding of cell biological and molecular changes associated with the development of this disease is urgently needed. Recently, application of a number of these have been tested. Whereas some do not seem to have prognostic value over the available classical prognostic markers, quantitative nuclear morphometric measurement and assessment of cadherin-mediated adhesion complexes (catenin immunohistochemistry) have opened new prospectives.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8946626

Source DB:  PubMed          Journal:  Semin Urol Oncol        ISSN: 1081-0943


  2 in total

1.  Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma.

Authors:  Yasuo Awakura; Eijiro Nakamura; Takeshi Takahashi; Hirokazu Kotani; Yoshiki Mikami; Tadashi Kadowaki; Akira Myoumoto; Hideo Akiyama; Noriyuki Ito; Toshiyuki Kamoto; Toshiaki Manabe; Hitoshi Nobumasa; Gozoh Tsujimoto; Osamu Ogawa
Journal:  J Cancer Res Clin Oncol       Date:  2008-05-16       Impact factor: 4.553

Review 2.  The role of adjuvant immunotherapy in renal cell carcinoma.

Authors:  Peter F A Mulders; Pieter H M De Mulder
Journal:  Curr Urol Rep       Date:  2002-02       Impact factor: 2.862

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.